Human CD10 antibody, also known as common acute lymphoblastic leukemia (CALLA), has been shown to react with TdT+ lymphoblastic leukemia, follicular germinal cell lymphoma, Burkitt’s lymphoma and chronic myelocytic leukemia. CD10 also marks normal early lymphoid progenitor cells, immature B-cells in adult bone marrow and germinal cells in normal tonsil and normal lymphoid tissue. It is also expressed in some non-lymphoid tissues such as fibroblasts, breast myoepithelium and brush border of kidney. CD10 antibody may be used in a panel for mantle cell lymphoma with Cyclin D1 (+), CD43 (+), CD5 (+), IgM (+), CD23 (-) and CD10 (-).
|Download Data Sheet
|Download RUO Data Sheet
|Download SDS Sheet
Regulatory Notice: Biocare’s IVD-labeled products comply with US-FDA and European IVDD regulation. Other regions may have additional requirements for such labeling, please contact your local distributor.
1. Kaufmann O, et al. Am J Clin Pathol. 1999 Jan; 111(1):117-22.
2. Kurtin PJ, et al. Am J Clin Pathol. 1999 Sep; 112(3):319-29.
3. de Leon ED, et al. Mod Pathol. 1998 Nov; 11(11):1046-51.
4. de Boer CJ, et al. Ann Oncol. 1997; 8 Suppl 2:109-17.